DRKS00025396尚未招募不适用
Establishing Pheno- and Genotyping - PrePRECISE
Institut für Experimentelle und Klinische Pharmakologie, UKSH, Campus Kiel0 个研究点目标入组 150 人开始时间: 2021年8月4日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Informed consent
- •(Planned) use of at least one of the following antidepressants:
- •o citalopram
- •o sertraline
- •o venlafaxine
- •o paroxetine
- •o mirtazapine
- •(Planned) assessment of Hamilton depression scores (HAM-D17)
排除标准
- •Not of legal age
- •Non-compliance and other study-endangering factors as determined by the investigator
研究者
相似试验
招募中
不适用
Genotypoing and data collection for the natural cystic fibrosis registryHuman Genetics and Inherited Disorders - Cystic fibrosisCystic fibrosisACTRN12605000734662Australian Cystic Fibrosis Trust
招募中
不适用
Congenital heart defectsCTRI/2021/06/034215Department of Biotechnology Ministry of Science and Technology Government of India
招募中
不适用
Discovery and validation of genetic markers to establish effective indications of anti-osteoporotic drugsDiseases of the musculo-skeletal system and connective tissueKCT0000426Asan Medical Center6,604
招募中
不适用
Investigations on the individual phenotype and genetic profile of sleep apnea syndromeG47.3Sleep apnoeaDRKS00003966Interdisziplinäres Schlafmedizinisches ZentrumCharité Universitätsmedizin Berlin6,000
招募中
不适用
Identification of genetic causes and designed therapy by large sized exome data establishment in Charcot-Marie-Tooth diseaseDiseases of the nervous systemKCT0000369Ewha Womans University Medical Center220